CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 90.70
-1.30 (-1.41%)
Sep 11, 2026, 1:30 PM CST
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 9.14 billion as of September 11, 2026. Its market cap has decreased by -20.95% in one year.
Market Cap
9.14B
Enterprise Value
9.37B
Revenue
1.87B
Ranking
n/a
PE Ratio
15.43
Stock Price
90.70
ChartMarket Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 9.14B, an increase of 22.39%. That is a compound annual growth rate of 1.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 9.14B | -1.18% |
| Dec 31, 2025 | 9.25B | 11.39% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 1.88T |
| Formosa Plastics | 424.59B |
| Formosa Chemicals & Fibre | 419.96B |
| China Steel | 293.40B |
| Coremax | 9.56B |
| Keding Enterprises | 9.54B |
| Tang Eng Iron Works | 9.22B |
| Southeast Cement | 9.16B |